NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
11/03/2023
Back to search
Official data from USPTO
ARISE INFUSION THERAPY SERVICES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
18
Latest update
11/03/2023
Trademark type
Combined
Nice classes
44
Filing date
05/15/2017
Registration date
12/19/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/03/2023
Last transaction
11/03/2023
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
First use anywhere
09/10/2015
First use in commerce
07/14/2016
Drawing code
3
Owner type
03
Owner location
WHEATON, MD, US
Examiner
DOMBROW, COLLEEN
Law office
L10
Current location
TMEG LAW OFFICE 101
Mark description
The mark consists of a blue curved line at the top of the mark, directly above the words "arise infusion" in dark blue lowercase letters, connecting the "i" in "arise" with the second "i" in "infusion". The words "THERAPY SERVICES" appear in light blue capital letters at the bottom of the mark.
Holders and representatives
Holders
ARTHRITIS AND RHEUMATISM ASSOCIATES, P.C.
Representatives
ARTHRITIS AND RHEUMATISM ASSOCIATES, P.C.
Technical classification
Nice Classes
Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 44
Outpatient medical provider servicesadministering of infusible and injectable drug therapy by health care professionals in a safe and controlled environment
Publications
History of USPTO decisions and trademark events.
18 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
11/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/02/2023
ES8R
TEAS SECTION 8 RECEIVED
12/19/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/19/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
12/19/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/03/2017
PUBO
PUBLISHED FOR OPPOSITION
10/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/13/2017
ALIE
ASSIGNED TO LIE
08/25/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
08/11/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/11/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
08/11/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/11/2017
DOCK
ASSIGNED TO EXAMINER
08/09/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
05/20/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/19/2017
Continuous trademark protection
Get notified about every new filing that threatens ARISE INFUSION THERAPY SERVICES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.